Hosted on MSN2d
Island Pharmaceuticals starts phase 2b dengue trialIsland Pharmaceuticals has commenced its phase 2b clinical trial of lead drug ISLA-101 – for potentially treating dengue ...
Stockhead on MSN1d
Long Shortz with Island Pharmaceuticals: Phase 2b trial into dengue fever kicks offIsland Pharmaceuticals joins Fraser Palamara on Stockhead TV to talk about its Phase 2b trial of ISLA-101 in dengue fever. ... Read More The post Long Shortz with Island Pharmaceuticals: Phase 2b ...
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Island Pharmaceuticals Ltd is set to hold an Extraordinary General Meeting on January 28, 2025, encouraging ...
Island Pharmaceuticals Ltd (AU:ILA) has released an update. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter ...
Island Pharmaceuticals Ltd (AU:ILA) has released an update. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter ...
Stockhead on MSN2d
Health Check: Which stock just dumped 19% on earnings downgrade?Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...
Long Island schools have produced dozens of scholars year after year. The region had 50 semifinalists last year and three of ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback